164 related articles for article (PubMed ID: 34229467)
1. Safety, Efficacy, and Cost of 0.4-mg Versus 2-mg Intranasal Naloxone for Treatment of Prehospital Opioid Overdose.
Thompson J; Salter J; Bui P; Herbert L; Mills D; Wagner D; Brent C
Ann Pharmacother; 2022 Mar; 56(3):285-289. PubMed ID: 34229467
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Naloxone Redosing in the Age of the New Opioid Epidemic.
Klebacher R; Harris MI; Ariyaprakai N; Tagore A; Robbins V; Dudley LS; Bauter R; Koneru S; Hill RD; Wasserman E; Shanes A; Merlin MA
Prehosp Emerg Care; 2017; 21(6):682-687. PubMed ID: 28686547
[TBL] [Abstract][Full Text] [Related]
3. Management of Suspected Opioid Overdose With Naloxone in Out-of-Hospital Settings: A Systematic Review.
Chou R; Korthuis PT; McCarty D; Coffin PO; Griffin JC; Davis-O'Reilly C; Grusing S; Daya M
Ann Intern Med; 2017 Dec; 167(12):867-875. PubMed ID: 29181532
[TBL] [Abstract][Full Text] [Related]
4. Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency.
Jeffery RM; Dickinson L; Ng ND; DeGeorge LM; Nable JV
J Am Coll Health; 2017 Apr; 65(3):212-216. PubMed ID: 28059635
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Complications of Opioid Overdose Treated With Naloxone.
Farkas A; Lynch MJ; Westover R; Giles J; Siripong N; Nalatwad A; Pizon AF; Martin-Gill C
Ann Emerg Med; 2020 Jan; 75(1):39-48. PubMed ID: 31182316
[TBL] [Abstract][Full Text] [Related]
6. Basic and Advanced EMS Providers Are Equally Effective in Naloxone Administration for Opioid Overdose in Northern New England.
Gulec N; Lahey J; Suozzi JC; Sholl M; MacLean CD; Wolfson DL
Prehosp Emerg Care; 2018; 22(2):163-169. PubMed ID: 29023172
[TBL] [Abstract][Full Text] [Related]
7. Naloxone Administration for Opioid Overdose Reversal in the Prehospital Setting: Implications for Pharmacists.
Weaver L; Palombi L; Bastianelli KMS
J Pharm Pract; 2018 Feb; 31(1):91-98. PubMed ID: 28399697
[TBL] [Abstract][Full Text] [Related]
8. Degree of Bystander-Patient Relationship and Prehospital Care for Opioid Overdose.
McCann MK; Jusko TA; Jones CMC; Seplaki CL; Cushman JT
Prehosp Emerg Care; 2021; 25(1):82-90. PubMed ID: 32073921
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults.
Dale O
Expert Opin Drug Metab Toxicol; 2022 Mar; 18(3):203-217. PubMed ID: 35500297
[TBL] [Abstract][Full Text] [Related]
10. Importance of Analyzing Intervals to Emergency Medical Service Treatments.
Ornato JP; Dunbar EG; Harbour W; Ludin T; Peberdy MA
Prehosp Emerg Care; 2023; 27(7):927-933. PubMed ID: 35894873
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting.
Barton ED; Colwell CB; Wolfe T; Fosnocht D; Gravitz C; Bryan T; Dunn W; Benson J; Bailey J
J Emerg Med; 2005 Oct; 29(3):265-71. PubMed ID: 16183444
[TBL] [Abstract][Full Text] [Related]
12. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose.
Robertson TM; Hendey GW; Stroh G; Shalit M
Prehosp Emerg Care; 2009; 13(4):512-5. PubMed ID: 19731165
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose.
Kerr D; Kelly AM; Dietze P; Jolley D; Barger B
Addiction; 2009 Dec; 104(12):2067-74. PubMed ID: 19922572
[TBL] [Abstract][Full Text] [Related]
15. Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial.
Dietze P; Jauncey M; Salmon A; Mohebbi M; Latimer J; van Beek I; McGrath C; Kerr D
JAMA Netw Open; 2019 Nov; 2(11):e1914977. PubMed ID: 31722024
[TBL] [Abstract][Full Text] [Related]
16. Use of Intranasal Naloxone by Basic Life Support Providers.
Weiner SG; Mitchell PM; Temin ES; Langlois BK; Dyer KS
Prehosp Emerg Care; 2017; 21(3):322-326. PubMed ID: 28166446
[TBL] [Abstract][Full Text] [Related]
17. Evidence-Based Guidelines for EMS Administration of Naloxone.
Williams K; Lang ES; Panchal AR; Gasper JJ; Taillac P; Gouda J; Lyng JW; Goodloe JM; Hedges M
Prehosp Emerg Care; 2019; 23(6):749-763. PubMed ID: 30924736
[TBL] [Abstract][Full Text] [Related]
18. Pitfalls of intranasal naloxone.
Zuckerman M; Weisberg SN; Boyer EW
Prehosp Emerg Care; 2014; 18(4):550-4. PubMed ID: 24830404
[TBL] [Abstract][Full Text] [Related]
19. Prehospital Naloxone Administration as a Public Health Surveillance Tool: A Retrospective Validation Study.
Lindstrom HA; Clemency BM; Snyder R; Consiglio JD; May PR; Moscati RM
Prehosp Disaster Med; 2015 Aug; 30(4):385-9. PubMed ID: 26061280
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose - New York, March 2022-August 2023.
Payne ER; Stancliff S; Rowe K; Christie JA; Dailey MW
MMWR Morb Mortal Wkly Rep; 2024 Feb; 73(5):110-113. PubMed ID: 38329911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
